首页> 外文期刊>International Journal of Experimental Diabetes Research: Experimental Diabesity Research >CCAAT/Enhancer-Binding Protein β Mediates Oxygen-Induced Retinal Neovascularization via Retinal Vascular Damage and Vascular Endothelial Growth Factor
【24h】

CCAAT/Enhancer-Binding Protein β Mediates Oxygen-Induced Retinal Neovascularization via Retinal Vascular Damage and Vascular Endothelial Growth Factor

机译:CCAAT / Enhancer结合蛋白β通过视网膜血管损伤和血管内皮生长因子介导氧诱导的视网膜新血管形成

获取原文
获取外文期刊封面目录资料

摘要

Objective. To evaluate the role of CCAAT/enhancer-binding protein β (C/EBP β) in retinal neovascularization (RNV) in an oxygen-induced retinopathy (OIR) model. Methods. Rats with OIR were exposed to alternating hypoxic and hyperopic conditions for 14 days. Then, the rats with OIR were assigned randomly to groups that received intravitreal injections of either shRNA lentiviral particles targeting C/EBP β (LV.shC/EBP β) or control particles (LV.shScrambled). The effectiveness of transduction using intravitreal injection of C/EBP β shRNA was examined in rats with OIR. The retinal vascular damage and accumulation of RNV were determined by retinal fluorescein-dextran perfusion, retinal ADPase staining, and periodic acid-Schiff (PAS) staining. Retinal function was recorded by electroretinogram responses to full-field light flashes. Reverse transcriptase-polymerase chain reaction (RT-PCR) and western blot analyses were used to measure mRNA and protein levels of C/EBP β and vascular endothelial growth factor (VEGF). The expression of p-C/EBP β was also examined by western blot analyses. The location of C/EBP β expression in the retina was determined by immunohistochemistry. Results. In OIR rats, the expression levels of C/EBP β and VEGF were significantly increased at both the mRNA and protein levels (). The p-C/EBP β expression was consistent with the level of C/EBP β. C/EBP β was predominantly localized to the ganglion cell layer (GCL) and the inner nuclear layer (INL). The retinal C/EBP β level was significantly reduced in tissues from rats with OIR transduced with LV.shC/EBP β compared with tissues from those transduced with LV.shScrambled (). Compared with those of the rats with OIR in the LV.shScrambled group, nonperfused retinal areas, neovascular tufts, pericyte death, and the ratio of endothelial cells to pericytes in the LV.shC/EBP β group were significantly reduced. In OIR rats, retinal function was impaired. There was no significant change in retinal dysfunction between the LV.shC/EBP β group and the LV.shScrambled group. The levels of VEGF mRNA and protein in the LV.shC/EBP β group were also decreased significantly compared with those of the rats with OIR in the LV.shScrambled group (). Conclusions. C/EBP β shRNA inhibits RNV in OIR. A potential mechanism may be that the activity of C/EBP β increases with its overexpression, which in turn aggravates the amount of the retinal vascular damage and promotes transcription of VEGF. C/EBP β might be a new therapeutic target for preventing RNV.
机译:客观的。评价CCAAT /增强剂结合蛋白β(C / EBPβ)在氧诱导的视网膜病变(OIR)模型中的视网膜新生血管(RNV)中的作用。方法。用OIR的大鼠暴露于交替的缺氧和远处条件下14天。然后,随机分配具有OIR的大鼠,以接受靶向C /EBPβ(LV.SHC / EBPβ)或对照颗粒(LV.SHSCLAMBLAMB)的ShRNA慢病毒颗粒的玻璃体内注射的基团。用OIR的大鼠检查使用玻璃体内注射C /EBPβCRNA进行转导的有效性。通过视网膜荧光素 - 葡聚糖灌注,视网膜ADPase染色和周期性酸 - 席夫(PAS)染色来确定RNV的视网膜血管损伤和积累。通过电气图函数记录视网膜功能对全场灯闪光的反应记录。逆转录酶 - 聚合酶链反应(RT-PCR)和Western印迹分析用于测量C /EBPβ和血管内皮生长因子(VEGF)的mRNA和蛋白水平。通过Western印迹分析检查p-C /EBPβ的表达。视网膜中C /EBPβ表达的位置通过免疫组化测定。结果。在OIR大鼠中,在mRNA和蛋白质水平()中,C /EBPβ和VEGF的表达水平显着增加。 P-C /EBPβ表达与C / EBPβ的水平一致。 C / EBPβ主要定位于神经节细胞层(GCL)和内核层(INL)。与用LV.Shscrambled()转导的组织的大鼠与OIR转导的大鼠的组织中,视网膜C /EBPβ水平显着降低。与LV.Shscrambled组中的大鼠的大鼠相比,无灌条视网膜区域,新生血管簇,细胞死亡和内皮细胞与LV.SHC /EBPβ组中内皮细胞的比例显着降低。在OIR大鼠中,视网膜功能受到损害。 LV.SHC / EBPβ组和LV.Shsclambled组之间的视网膜功能障碍无明显变化。与LV.Shsclambled组()中的OIR中的大鼠相比,LV.SHC /EBPβ组中VEGF mRNA和蛋白质的水平也显着降低。结论。 C /EBPβShRNA抑制OIR中的RNV。潜在机制可能是C / EBPβ的活性随其过表达增加,这反过来加剧了视网膜血管损伤的量并促进了VEGF的转录。 C /EBPβ可能是预防RNV的新治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号